![]() Remote cardiac monitoring has become part of the standard of care for cardiac patients, especially those with implantable cardiac devices. The physician can facilitate decision-making with control of all reporting and get all the data needed to optimize diagnosis accuracy.By recording every single heartbeat and providing on-demand access to 100% of acquired heartbeats, the data can enhance the clinician’s ability to detect-and make timely diagnoses of atrial fibrillation, tachycardia, and other arrhythmias.Eliminates the need for intermediaries in patient enrollments, IDTF data delays and helps to gain control of patient compliance.By remotely transitioning the monitor between Holter, Event, and MCT during monitoring periods (depending on patient need), RPM streamlines office and hospital visits.In addition to benefitting the patient, cardiac RPM devices help the clinician as well: MoMe presents this information in a HIPAA-compliant portal that helps to protect sensitive patient health information. Automated reports show onset, offset, and other supplementary data that any cardiologist may use to verify or rule out cardiac events. Using a one-piece monitor, MoMe continuously records telemetry data, uploading it to a cloud-based platform that clinicians may access anytime, anywhere. InfoBionic introduced the MoMe Kardia as the first mobile cardiac telemetry (MCT) technology that provides near real-time on-demand full disclosure of ECG data 24/7. Some studies already show that patients using RPM showed a 50% drop in mortality from arrhythmias and congestive heart failure compared to those receiving standard, in-person follow-up. ![]() Cardiology was one of the first medical specialties to incorporate RPM into standard practice. RPM uses innovative technological tools to gather and track patient data outside standard healthcare settings. But not all RPM devices are created equal, and doctors need to feel confident that their choice of technology provides a truly comprehensive picture of a patient’s health,” explains Stuart Long, CEO of InfoBionic, a digital health technology company. “COVID-19 strained our already overburdened healthcare system to the max, and many doctors chose to go with remote patient monitoring to help alleviate that strain and keep patients safe from COVID-19. And now, as America seems to be rounding out of the pandemic, telehealth and RPM are here to stay-so believes the American Medical Association. Even before the pandemic, nine out of ten healthcare providers indicated they were evaluating or had already invested in RPM technologies to better assist their patients. ![]() In efforts to keep patients safe, doctors across the country turned to RPM to evaluate and monitor patients while keeping them at home. ![]() It’s no secret that the use of telehealth technologies rose dramatically with the onset of the COVID-19 pandemic. As the pandemic is showing signs of abating, InfoBionic CEO Stuart Long addressed in a press release how remote patient monitoring (RPM) technology ensures telehealth is here to stay. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |